Remote CPAP monitoring for severe obstructive sleep apnea in primary care
Official title: Efficacy of Telemonitoring With CPAP in Severe Obstructive Sleep Apnea: A Randomized Controlled Trial in Primary Health Care
Run by Federal University of São Paulo · NCT07464262 · Data updated 2026-11-12
This will test whether remote monitoring of CPAP devices helps adults with severe obstructive sleep apnea treated in primary care use their therapy more and improve symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Federal University of São Paulo Academic / other |
| Locations | 1 site (São Paulo, São Paulo) |
| Status | Recruiting |
| Started | October 6, 2025 |
| Main results expected | October 2026 |
| Study ends | July 2027 |
| Registry record updated | March 11, 2026 |
| Trial ID | NCT07464262 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–75 with polysomnography-confirmed severe OSA (AHI ≥30) who are new CPAP users (≤30 days) and live within the Southeast Regional Health Coordination coverage area are ideal candidates.
✕Probably not a fit
Those with predominant central sleep apnea, a current need for bilevel/noninvasive ventilation, prior prolonged CPAP use, recent unstable severe comorbidity, or severe cognitive impairment are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will randomize 200 adults with severe OSA who are new CPAP users within the Southeast Regional Health Coordination of São Paulo to receive either telemonitoring via the AirView® platform and myAir® app or usual primary care follow-up. The telemonitoring arm allows clinicians to track device usage and performance remotely and provide timely support for technical issues and adherence barriers. Primary outcomes focus on CPAP adherence and relevant clinical measures, with secondary outcomes including patient-reported symptoms and quality of life. The trial is designed to test implementation of digital CPAP follow-up within Brazil's public primary care network.
Why it matters
Potential benefit: If successful, the intervention could increase long-term CPAP use and improve symptoms and downstream health risks for people with severe OSA in primary care.
How similar studies have gone: Previous trials and implementation studies have shown telemonitoring can improve CPAP adherence, but results vary and evidence is less established in public primary care settings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 75 years. * Diagnosis of severe obstructive sleep apnea (OSA) confirmed by polysomnography with apnea-hypopnea index (AHI) ≥30 events/hour. * New CPAP users (≤30 days since initiation of CPAP therapy). * Resident within the coverage area of the Southeast Regional Health Coordination (CRS Sudeste), São Paulo, Brazil. * Ability to understand and sign the informed consent form. Exclusion Criteria: * Previous CPAP use for more than 30 days prior to enrollment. * Indication for bilevel ventilation (BiPAP) or non-invasive ventilation due to conditions such as hypoventilation syndromes, chronic hypercapnic COPD, or neuromuscular diseases. * Predominant central sleep apnea (≥50% central events) or Cheyne-Stokes respiration. * Recent unstable or severe comorbidity (e.g., decompensated heart failure, acute coronary syndrome within 30 days, stroke within 3 months). * Severe cognitive impairment or psychiatric disorder that prevents understanding of study procedures or adherence. * Conditions preventing safe use of CPAP mask (e.g., major craniofacial deformities, facial trauma, extensive facial skin lesions). * Inability to maintain follow-up in primary care services of CRS Sudeste. * Participation in another interventional clinical trial that may interfere with study outcomes.
Where it's running
-
Primary Health Care Units - Southeast Regional Health Coordination
São Paulo, São Paulo, Brazil Recruiting
Study contacts
- Principal investigator: Gustavo Moreira, MD, PhD — Federal University of São Paulo
- Study coordinator: Andre Morente, PharmD
- Email: crssudeste.andre@gmail.com
- Phone: +55 11 989633988
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
F&P Mask usability in home PAP/NIV care for adults with chronic breathing conditions
This study tests how well the F&P Licorice Mask works at home for adults who already use PAP or NIV therapy.
-
Sleep apnea biomarkers and CPAP use after diagnosis
This study tests whether biomarkers from a diagnostic sleep study can predict how well adults with newly diagnosed obstructive sleep apnea will stick to CPAP therapy after about 3 months.
-
Using the PLATO Questionnaire in Oral Appliance Therapy for Obstructive Sleep Apnea
This real-world study tests whether the PLATO questionnaire can be feasibly used in dental sleep clinics for patients receiving oral appliance therapy for obstructive sleep apnea.
-
Managing COMISA: adding daridorexant to CPAP may help sleep and CPAP use
This study tests whether adding daridorexant to CPAP helps people with COMISA better stick with CPAP and feel better.
-
OSA Screening in Diverse Populations
This study tests how common obstructive sleep apnea is across community members and people with certain diseases in China, using screening questionnaires and polysomnography or portable sleep monitors.
-
Wall Squat Exercise to Help Lower Blood Pressure in Adults with Hypertension and Sleep Apnea
This study tests whether doing an isometric wall squat can lower blood pressure in adults who have high blood pressure and sleep apnea treated with CPAP.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.